Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovascular disease is one of the most intensively studied issues in all of medicine. This volume is an innovative approach to the identification and management of lipid disorders. Organized as a series of questions, each chapter presents a detailed yet accessible discussion of the problems posed. The questions discussed are among the most frequently encountered at both primary care and specialty conferences throughout the world. Carefully weighing the risks and benefits of specific therapies, the ensuing discourse presents a fair, balanced approach to conceptual controversies as well as exploring the diagnostic and therapeutic dilemmas that may arise. This book is designed for the busy clinical practitioner who is in search of authoritative discussion that is balanced by evidence-based, best practice recommendations. It is intended as a resource for practitioners of primary care, cardiology, and endocrinology.